{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:03:04Z","timestamp":1785528184744,"version":"3.56.0"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,12,15]]},"DOI":"10.2169\/internalmedicine.3204-19","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T22:02:49Z","timestamp":1564524169000},"page":"3537-3543","source":"Crossref","is-referenced-by-count":17,"title":["Immunoglobulin G4-related Liver Disease Overlapping with Non-alcoholic Steatohepatitis That Was Diagnosed Simultaneously with Autoimmune Pancreatitis: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"58","author":[{"given":"Kotaro","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kuniyoshi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Tsunashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738, 2001.","DOI":"10.1056\/NEJM200103083441005"},{"key":"2","unstructured":"2. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94: e680, 2015."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28: 1193-1203, 2004.","DOI":"10.1097\/01.pas.0000136449.37936.6c"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 20: 884-894, 2007.","DOI":"10.1038\/modpathol.3800836"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 56: 1471-1472, 2007.","DOI":"10.1136\/gut.2007.122283"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Umemura T, Zen Y, Hamano H, et al. Immunoglobulin G4-hepatopathy: association of immunoglobulin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46: 463-471, 2007.","DOI":"10.1002\/hep.21700"},{"key":"7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.23730","volume":"52","author":"T Umemura","year":"2010","unstructured":"7. Umemura T, Zen Y, Nakanuma Y, et al. Another cause of autoimmune hepatitis. Hepatology 52: 389-390, 2010.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 46 (Suppl 1): 48-55, 2011.","DOI":"10.1007\/s00535-010-0323-4"},{"key":"9","unstructured":"9. Ishizu Y, Ishigami M, Kuzuya T, et al. Immunoglobulin G4-associated autoimmune hepatitis later complicated by autoimmune pancreatitis: a case report. Hepatol Res 46: 601-606, 2016."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakanuma Y, Ishizu Y, Zen Y, et al. Histopathology of IgG4-related autoimmune hepatitis and IgG4- related hepatopathy in IgG4-related disease. Semin Liver Dis 36: 229-241, 2016.","DOI":"10.1055\/s-0036-1584320"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Suto D, Murata K, Otake T, et al. A case of IgG4-related autoimmune hepatitis incidentally found by liver injury. Kanzo 59: 277-283, 2018.","DOI":"10.2957\/kanzo.59.277"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Araki T, Arinaga-Hino T, Koga H, et al. Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis. Hepatol Res 48: 937-944, 2018.","DOI":"10.1111\/hepr.13188"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chung H, Watanabe T, Kudo M, et al. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int 30: 222-231, 2010.","DOI":"10.1111\/j.1478-3231.2009.02092.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Aydemir Y, Akcoren Z, Demir H, et al. Clinical and histopathological features of immunoglobulin G4-associated autoimmune hepatitis in children. J Gastroenterol Hepatol 34: 742-746, 2019.","DOI":"10.1111\/jgh.14525"},{"key":"15","unstructured":"15. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474, 1999."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Niwa H, Sasaki M, Haratake J, et al. Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis. Hepatol Res 37: 923-931, 2007.","DOI":"10.1111\/j.1872-034X.2007.00150.x"},{"key":"17","unstructured":"17. Tsuneyama K, Baba H, Kikuchi K, et al. Autoimmune features in metabolic liver disease: a single-center experience and review of the literature. Clin Rev Allergy Immunol 45: 143-148, 2013."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yatsuji S, Hashimoto E, Kaneda H, et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol 40: 1130-1138, 2005.","DOI":"10.1007\/s00535-005-1711-z"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 99: 1316-1320, 2004.","DOI":"10.1111\/j.1572-0241.2004.30444.x"},{"key":"20","unstructured":"20. Loria P, Lonardo A, Leonardi F, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 48: 2173-2181, 2003."},{"key":"21","unstructured":"21. Fukuda S, Komori A, Itoh M, et al. Histological remission during corticosteroid therapy of overlapping nonalcoholic steatohepatitis and autoimmune hepatitis: case report and literature review. Case Rep Gastroenterol 5: 553-557, 2011."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Komura T, Ohta H, Seike T, et al. The efficacy of corticosteroid therapy in a patient with non-alcoholic steatohepatitis overlapping autoimmune hepatitis. Intern Med 57: 807-812, 2018.","DOI":"10.2169\/internalmedicine.8887-17"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kashiwagi Y, Hatsushika T, Tsutsumi N, et al. Gastrointestinal and liver lesions in primary childhood Sj\u00f6gren syndrome. Clin Rheumatol 36: 1433-1435, 2017.","DOI":"10.1007\/s10067-017-3599-4"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Chen Y, Wang N, Chen Y, et al. The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: a new insight from SPECT-China study. Autoimmunity 51: 238-244, 2018.","DOI":"10.1080\/08916934.2018.1488968"},{"key":"25","unstructured":"25. Ogdie A, Grewal SK, Noe MH, et al. Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study. J Invest Dermatol 138: 760-767, 2018."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tabarkiewicz J, Pogoda K, Karczmarczyk A, et al. The role of IL-17 and Th17 lymphocytes in autoimmune diseases. Arch Immunol Ther Exp (Warsz) 63: 435-449, 2015.","DOI":"10.1007\/s00005-015-0344-z"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Meng F, Wang K, Aoyama T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143: 765-766.e1-3, 2012.","DOI":"10.1053\/j.gastro.2012.05.049"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Liu Y, She W, Wang F, et al. 3, 3&apos;-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg\/Th17 cells to Treg dominance. Int Immunopharmacol 23: 489-498, 2014.","DOI":"10.1016\/j.intimp.2014.09.024"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rolla S, Alchera E, Imarisio C, et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. Clin Sci (Lond) 130: 193-203, 2016.","DOI":"10.1042\/CS20150405"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Giles DA, Moreno-Fernandez ME, Stankiewicz TE, et al. Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis. PLoS One 11: e0149783, 2016.","DOI":"10.1371\/journal.pone.0149783"},{"key":"31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","volume":"166","author":"Y Tang","year":"2011","unstructured":"31. Tang Y, Bian Z, Zhao L, et al. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol 166: 281-290, 2011.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tedesco D, Thapa M, Chin CY, et al. Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic gd T-cell receptor-positive cells and pathogenesis of cholestatic liver disease. Gastroenterology 154: 2178-2193, 2018.","DOI":"10.1053\/j.gastro.2018.02.019"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/24\/58_3204-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T03:42:11Z","timestamp":1576899731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/24\/58_3204-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,15]]},"references-count":32,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3204-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,15]]}}}